Healthcare
Sunday, August 21, 2016
Actelion completes first-line share purchase program
ZURICH, Aug 22 (Reuters) - Swiss biotech company Actelion
has completed its first-line share purchase programme
which represented more than 8 percent of its shares, it said on
Monday.
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment